Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production
The clinical demand of plasmid DNA (pDNA) has been increasing constantly. An exponential‐fed perfusion (EFP) culture is a new mode for plasmid production for clinical trials and commercialization. However, the culture conditions may lead to cell filamentation and growth cessation. In this study, the...
Gespeichert in:
Veröffentlicht in: | Biotechnology and applied biochemistry 2015-11, Vol.62 (6), p.795-805 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 805 |
---|---|
container_issue | 6 |
container_start_page | 795 |
container_title | Biotechnology and applied biochemistry |
container_volume | 62 |
creator | Munguía-Soto, Rodolfo García-Rendón, Aurora Garibay-Escobar, Adriana Guerrero-Germán, Patricia Tejeda-Mansir, Armando |
description | The clinical demand of plasmid DNA (pDNA) has been increasing constantly. An exponential‐fed perfusion (EFP) culture is a new mode for plasmid production for clinical trials and commercialization. However, the culture conditions may lead to cell filamentation and growth cessation. In this study, the variation of the physiological state and the plasmid contents of Escherichia coli DH5α hosting pVAX1‐NH36 in an EFP culture for application as a Leishmaniasis vaccine was investigated. The culture performance was monitored using flow cytometry (FC) and real‐time quantitative PCR. The FC studies showed a high viability of cell population and a constant distribution of complexity and size. A high homogeneity of pDNA (>95 % of supercoiled) was obtained, which might be attributed to a better culture environment. The obtained plasmid specific and volumetric yields of 1.8 mg/g dcw and 36.5 mg/L represent typical values for laboratory‐scale plasmid production in a defined medium. A segregated kinetic model of the perfusion system was developed and fitted to the experimental data (R2 > 0.96). A practical conclusion of this work is that a space–time yield analysis of a bioprocess requires a viability evaluation. This new strategy of culture operation might help in the efficient production of pDNA for therapeutic use. |
doi_str_mv | 10.1002/bab.1339 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1800486292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1776658829</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5089-dcd38d3060438b0ccca45b6374654bc7a2e2056fdfc15b57d93b8a4dfc6a42923</originalsourceid><addsrcrecordid>eNqNkdtqFDEYgIModq2CTyABb7yZ-k_Oc7k97QplvbCidyGTyeymnZ2MyYw9vFVfxGcypWsFQehV-OHjy598CL0t4aAEIB9rUx-UlFbP0KxkEgolGXuOZqAULxgv6R56ldIFACipyEu0RzjnQikyQ7df3Dq6tRldg9cxXI0bfOl7N3qbcGjxSbIbF73deINt6Dw-XvJfd8VqSQX2PXbXQ-hdP3rTFW02DC62U_Khx3bqxik63IaIh-PVHP801mYxHmJoJjtm5jV60ZouuTe7cx99PT05P1oWZ58Xn47mZ4XloKqisQ1VDQUBjKoarLWG8VpQyQRntZWGOAJctE1rS15z2VS0VoblURhGKkL30YcHb776x-TSqLc-Wdd1pndhSrpUAEyJJ6FSCsHzx1VPQEXenkFVZvT9P-hFmGKf36yJormRYFT-FdoYUoqu1UP0WxNvdAn6vrLOlfV95Yy-2wmneuuaR_BP1gwUD8CV79zNf0X6cH64E-54n0Z3_cibeKmFpJLrb6uFPl-cfge5kHpFfwO4HL7v</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2838856437</pqid></control><display><type>article</type><title>Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Munguía-Soto, Rodolfo ; García-Rendón, Aurora ; Garibay-Escobar, Adriana ; Guerrero-Germán, Patricia ; Tejeda-Mansir, Armando</creator><creatorcontrib>Munguía-Soto, Rodolfo ; García-Rendón, Aurora ; Garibay-Escobar, Adriana ; Guerrero-Germán, Patricia ; Tejeda-Mansir, Armando</creatorcontrib><description>The clinical demand of plasmid DNA (pDNA) has been increasing constantly. An exponential‐fed perfusion (EFP) culture is a new mode for plasmid production for clinical trials and commercialization. However, the culture conditions may lead to cell filamentation and growth cessation. In this study, the variation of the physiological state and the plasmid contents of Escherichia coli DH5α hosting pVAX1‐NH36 in an EFP culture for application as a Leishmaniasis vaccine was investigated. The culture performance was monitored using flow cytometry (FC) and real‐time quantitative PCR. The FC studies showed a high viability of cell population and a constant distribution of complexity and size. A high homogeneity of pDNA (>95 % of supercoiled) was obtained, which might be attributed to a better culture environment. The obtained plasmid specific and volumetric yields of 1.8 mg/g dcw and 36.5 mg/L represent typical values for laboratory‐scale plasmid production in a defined medium. A segregated kinetic model of the perfusion system was developed and fitted to the experimental data (R2 > 0.96). A practical conclusion of this work is that a space–time yield analysis of a bioprocess requires a viability evaluation. This new strategy of culture operation might help in the efficient production of pDNA for therapeutic use.</description><identifier>ISSN: 0885-4513</identifier><identifier>EISSN: 1470-8744</identifier><identifier>DOI: 10.1002/bab.1339</identifier><identifier>PMID: 25556882</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Biotechnology ; Biotechnology - methods ; Cell culture ; Cell Survival ; Clinical trials ; Commercialization ; Constants ; Culture ; Culture Techniques - methods ; Deoxyribonucleic acid ; DNA ; E coli ; Escherichia coli ; Escherichia coli - cytology ; Escherichia coli - genetics ; Escherichia coli - growth & development ; exponential fed ; Fermentation ; Filamentation ; Flow cytometry ; Growth kinetics ; Homogeneity ; Kinetics ; Leishmaniasis ; Leishmaniasis Vaccines - genetics ; Models, Biological ; Perfusion ; perfusion culture ; plasmid DNA ; Plasmids ; Plasmids - genetics ; Strategy ; Vaccines ; Vaccines, DNA - genetics ; Vector-borne diseases ; Viability</subject><ispartof>Biotechnology and applied biochemistry, 2015-11, Vol.62 (6), p.795-805</ispartof><rights>2014 International Union of Biochemistry and Molecular Biology, Inc.</rights><rights>Copyright © 2015 International Union of Biochemistry and Molecular Biology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5089-dcd38d3060438b0ccca45b6374654bc7a2e2056fdfc15b57d93b8a4dfc6a42923</citedby><cites>FETCH-LOGICAL-c5089-dcd38d3060438b0ccca45b6374654bc7a2e2056fdfc15b57d93b8a4dfc6a42923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbab.1339$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbab.1339$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25556882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Munguía-Soto, Rodolfo</creatorcontrib><creatorcontrib>García-Rendón, Aurora</creatorcontrib><creatorcontrib>Garibay-Escobar, Adriana</creatorcontrib><creatorcontrib>Guerrero-Germán, Patricia</creatorcontrib><creatorcontrib>Tejeda-Mansir, Armando</creatorcontrib><title>Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production</title><title>Biotechnology and applied biochemistry</title><addtitle>Biotechnology and Applied Biochemistry</addtitle><description>The clinical demand of plasmid DNA (pDNA) has been increasing constantly. An exponential‐fed perfusion (EFP) culture is a new mode for plasmid production for clinical trials and commercialization. However, the culture conditions may lead to cell filamentation and growth cessation. In this study, the variation of the physiological state and the plasmid contents of Escherichia coli DH5α hosting pVAX1‐NH36 in an EFP culture for application as a Leishmaniasis vaccine was investigated. The culture performance was monitored using flow cytometry (FC) and real‐time quantitative PCR. The FC studies showed a high viability of cell population and a constant distribution of complexity and size. A high homogeneity of pDNA (>95 % of supercoiled) was obtained, which might be attributed to a better culture environment. The obtained plasmid specific and volumetric yields of 1.8 mg/g dcw and 36.5 mg/L represent typical values for laboratory‐scale plasmid production in a defined medium. A segregated kinetic model of the perfusion system was developed and fitted to the experimental data (R2 > 0.96). A practical conclusion of this work is that a space–time yield analysis of a bioprocess requires a viability evaluation. This new strategy of culture operation might help in the efficient production of pDNA for therapeutic use.</description><subject>Biotechnology</subject><subject>Biotechnology - methods</subject><subject>Cell culture</subject><subject>Cell Survival</subject><subject>Clinical trials</subject><subject>Commercialization</subject><subject>Constants</subject><subject>Culture</subject><subject>Culture Techniques - methods</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Escherichia coli - cytology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - growth & development</subject><subject>exponential fed</subject><subject>Fermentation</subject><subject>Filamentation</subject><subject>Flow cytometry</subject><subject>Growth kinetics</subject><subject>Homogeneity</subject><subject>Kinetics</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis Vaccines - genetics</subject><subject>Models, Biological</subject><subject>Perfusion</subject><subject>perfusion culture</subject><subject>plasmid DNA</subject><subject>Plasmids</subject><subject>Plasmids - genetics</subject><subject>Strategy</subject><subject>Vaccines</subject><subject>Vaccines, DNA - genetics</subject><subject>Vector-borne diseases</subject><subject>Viability</subject><issn>0885-4513</issn><issn>1470-8744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkdtqFDEYgIModq2CTyABb7yZ-k_Oc7k97QplvbCidyGTyeymnZ2MyYw9vFVfxGcypWsFQehV-OHjy598CL0t4aAEIB9rUx-UlFbP0KxkEgolGXuOZqAULxgv6R56ldIFACipyEu0RzjnQikyQ7df3Dq6tRldg9cxXI0bfOl7N3qbcGjxSbIbF73deINt6Dw-XvJfd8VqSQX2PXbXQ-hdP3rTFW02DC62U_Khx3bqxik63IaIh-PVHP801mYxHmJoJjtm5jV60ZouuTe7cx99PT05P1oWZ58Xn47mZ4XloKqisQ1VDQUBjKoarLWG8VpQyQRntZWGOAJctE1rS15z2VS0VoblURhGKkL30YcHb776x-TSqLc-Wdd1pndhSrpUAEyJJ6FSCsHzx1VPQEXenkFVZvT9P-hFmGKf36yJormRYFT-FdoYUoqu1UP0WxNvdAn6vrLOlfV95Yy-2wmneuuaR_BP1gwUD8CV79zNf0X6cH64E-54n0Z3_cibeKmFpJLrb6uFPl-cfge5kHpFfwO4HL7v</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Munguía-Soto, Rodolfo</creator><creator>García-Rendón, Aurora</creator><creator>Garibay-Escobar, Adriana</creator><creator>Guerrero-Germán, Patricia</creator><creator>Tejeda-Mansir, Armando</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>L7M</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201511</creationdate><title>Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production</title><author>Munguía-Soto, Rodolfo ; García-Rendón, Aurora ; Garibay-Escobar, Adriana ; Guerrero-Germán, Patricia ; Tejeda-Mansir, Armando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5089-dcd38d3060438b0ccca45b6374654bc7a2e2056fdfc15b57d93b8a4dfc6a42923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biotechnology</topic><topic>Biotechnology - methods</topic><topic>Cell culture</topic><topic>Cell Survival</topic><topic>Clinical trials</topic><topic>Commercialization</topic><topic>Constants</topic><topic>Culture</topic><topic>Culture Techniques - methods</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Escherichia coli - cytology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - growth & development</topic><topic>exponential fed</topic><topic>Fermentation</topic><topic>Filamentation</topic><topic>Flow cytometry</topic><topic>Growth kinetics</topic><topic>Homogeneity</topic><topic>Kinetics</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis Vaccines - genetics</topic><topic>Models, Biological</topic><topic>Perfusion</topic><topic>perfusion culture</topic><topic>plasmid DNA</topic><topic>Plasmids</topic><topic>Plasmids - genetics</topic><topic>Strategy</topic><topic>Vaccines</topic><topic>Vaccines, DNA - genetics</topic><topic>Vector-borne diseases</topic><topic>Viability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Munguía-Soto, Rodolfo</creatorcontrib><creatorcontrib>García-Rendón, Aurora</creatorcontrib><creatorcontrib>Garibay-Escobar, Adriana</creatorcontrib><creatorcontrib>Guerrero-Germán, Patricia</creatorcontrib><creatorcontrib>Tejeda-Mansir, Armando</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and applied biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Munguía-Soto, Rodolfo</au><au>García-Rendón, Aurora</au><au>Garibay-Escobar, Adriana</au><au>Guerrero-Germán, Patricia</au><au>Tejeda-Mansir, Armando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production</atitle><jtitle>Biotechnology and applied biochemistry</jtitle><addtitle>Biotechnology and Applied Biochemistry</addtitle><date>2015-11</date><risdate>2015</risdate><volume>62</volume><issue>6</issue><spage>795</spage><epage>805</epage><pages>795-805</pages><issn>0885-4513</issn><eissn>1470-8744</eissn><abstract>The clinical demand of plasmid DNA (pDNA) has been increasing constantly. An exponential‐fed perfusion (EFP) culture is a new mode for plasmid production for clinical trials and commercialization. However, the culture conditions may lead to cell filamentation and growth cessation. In this study, the variation of the physiological state and the plasmid contents of Escherichia coli DH5α hosting pVAX1‐NH36 in an EFP culture for application as a Leishmaniasis vaccine was investigated. The culture performance was monitored using flow cytometry (FC) and real‐time quantitative PCR. The FC studies showed a high viability of cell population and a constant distribution of complexity and size. A high homogeneity of pDNA (>95 % of supercoiled) was obtained, which might be attributed to a better culture environment. The obtained plasmid specific and volumetric yields of 1.8 mg/g dcw and 36.5 mg/L represent typical values for laboratory‐scale plasmid production in a defined medium. A segregated kinetic model of the perfusion system was developed and fitted to the experimental data (R2 > 0.96). A practical conclusion of this work is that a space–time yield analysis of a bioprocess requires a viability evaluation. This new strategy of culture operation might help in the efficient production of pDNA for therapeutic use.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25556882</pmid><doi>10.1002/bab.1339</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-4513 |
ispartof | Biotechnology and applied biochemistry, 2015-11, Vol.62 (6), p.795-805 |
issn | 0885-4513 1470-8744 |
language | eng |
recordid | cdi_proquest_miscellaneous_1800486292 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Biotechnology Biotechnology - methods Cell culture Cell Survival Clinical trials Commercialization Constants Culture Culture Techniques - methods Deoxyribonucleic acid DNA E coli Escherichia coli Escherichia coli - cytology Escherichia coli - genetics Escherichia coli - growth & development exponential fed Fermentation Filamentation Flow cytometry Growth kinetics Homogeneity Kinetics Leishmaniasis Leishmaniasis Vaccines - genetics Models, Biological Perfusion perfusion culture plasmid DNA Plasmids Plasmids - genetics Strategy Vaccines Vaccines, DNA - genetics Vector-borne diseases Viability |
title | Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A23%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Segregated%20growth%20kinetics%20of%20Escherichia%20coli%20DH5%CE%B1-NH36%20in%20exponential-fed%20perfusion%20culture%20for%20pDNA%20vaccine%20production&rft.jtitle=Biotechnology%20and%20applied%20biochemistry&rft.au=Mungu%C3%ADa-Soto,%20Rodolfo&rft.date=2015-11&rft.volume=62&rft.issue=6&rft.spage=795&rft.epage=805&rft.pages=795-805&rft.issn=0885-4513&rft.eissn=1470-8744&rft_id=info:doi/10.1002/bab.1339&rft_dat=%3Cproquest_cross%3E1776658829%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2838856437&rft_id=info:pmid/25556882&rfr_iscdi=true |